{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:56:12Z","timestamp":1790942172860,"version":"4.1.0"},"reference-count":50,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Zhejiang Provincial Medical and Health Science and Technology Plan Project","award":["Grant No. 2024KY488"],"award-info":[{"award-number":["Grant No. 2024KY488"]}]},{"name":"Shaoxing Municipal Health Science and Technology Plan Project","award":["Grant No. 2023SKY110"],"award-info":[{"award-number":["Grant No. 2023SKY110"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the efficacy of pharmacological interventions for vascular calcification and related outcomes in patients with chronic kidney disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, Web of Science, and the Cochrane Library were searched from inception to 1 May 2026. Randomized controlled trials comparing pharmacological interventions with placebo, standard care, or other controls in patients with chronic kidney disease were included. Primary outcomes were imaging-defined measures of vascular calcification, including coronary artery calcification Agatston score, percentage coronary artery calcification progression, coronary artery calcification volume change, and abdominal aortic calcification progression. Secondary outcomes included carotid intima-media thickness, serum calcification propensity (T50), arterial stiffness, calcification-related biomarkers, mineral metabolism parameters, and all-cause mortality. Mean differences or odds ratios with 95% confidence intervals were pooled using fixed- or random-effects models according to heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-eight randomized controlled trials involving 6330 participants were included. Pharmacological interventions did not significantly reduce the coronary artery calcification Agatston score, coronary artery calcification progression, coronary artery calcification volume change, abdominal aortic calcification progression, arterial stiffness, or all-cause mortality. Significant effects were observed for left carotid intima\u2013media thickness (mean difference \u22120.06\u2005mm, 95% confidence interval: \u22120.10 to \u22120.02), common carotid artery intima\u2013media thickness (mean differences \u22120.07\u2005mm, 95% confidence interval: \u22120.14 to \u22120.00), T50 change (mean differences 50.25\u2005min, 95% confidence interval: 34.68\u201365.82), and dephosphorylated\u2013uncarboxylated matrix Gla protein (mean differences \u2212504.97\u2005pmol\/L, 95% confidence interval: \u2212789.72 to \u2212220.22). Most mineral metabolism parameters were unchanged, although ionized calcium was modestly reduced. Effects varied by pharmacological strategy, supporting intervention-specific interpretation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pharmacological interventions did not show consistent benefits on imaging-defined vascular calcification in patients with chronic kidney disease. Improvements in T50, dephosphorylated-uncarboxylated matrix Gla protein, and selected carotid intima\u2013media thickness measures suggest pathway-specific biological or vascular effects that may precede or not directly translate into reduced structural calcification. Further randomized controlled trials with standardized imaging endpoints, longer follow-up, and clinically relevant subgroup reporting are needed to determine which therapeutic strategies provide meaningful vascular benefits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03000605261491505","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:06:02Z","timestamp":1790651162000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological interventions for vascular calcification in chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1177","volume":"54","author":[{"given":"Cuiyun","family":"Cao","sequence":"first","affiliation":[{"name":"Shaoxing Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxu","family":"Song","sequence":"additional","affiliation":[{"name":"Shaoxing Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shan","sequence":"additional","affiliation":[{"name":"Shaoxing Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7266-2191","authenticated-orcid":false,"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Shaoxing Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.0363"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2019.1595646"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-005-0668-6"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.11.012"},{"key":"e_1_3_3_8_2","first-page":"2077","article-title":"Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia","volume":"76","author":"Voelkl J","year":"2019","unstructured":"Voelkl J, Lang F, Eckardt K-U, et al. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Cell Mol Life Sci CMLS 2019; 76: 2077\u20132091.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00154"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018111150"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000000000092"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz204"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020020225"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044195"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021101327"},{"key":"e_1_3_3_16_2","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. The BMJ 2021; 372: n71.","journal-title":"The BMJ"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000001531"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-021-01050-w"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2016.12.008"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.13921217"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02312-2"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac191"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.3041"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16566"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000346427"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15112422"},{"key":"e_1_3_3_27_2","article-title":"Vitamin K2 alters bone metabolism markers in hemodialysis patients with a low serum parathyroid hormone level","volume":"117","author":"Ochiai M","year":"2011","unstructured":"Ochiai M, Nakashima A, Takasugi N, et al. Vitamin K2 alters bone metabolism markers in hemodialysis patients with a low serum parathyroid hormone level. Nephron Clin Pract 2011; 117: c15\u2013c19.","journal-title":"Nephron Clin Pract"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02275-2"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq725"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000488009"},{"key":"e_1_3_3_31_2","first-page":"1235","article-title":"Role of vitamin K 2 on matrix gla protein and vascular stiffness in hemodialysis patients","volume":"12","author":"Sarhan II","year":"2021","unstructured":"Sarhan II, Kamal OM, Said SA, et al. Role of vitamin K 2 on matrix gla protein and vascular stiffness in hemodialysis patients. J Cardiovasc Dis Res 2021; 12: 1235\u20131245.","journal-title":"J Cardiovasc Dis Res"},{"key":"e_1_3_3_32_2","first-page":"2300","article-title":"Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial","volume":"15","author":"Saritas T","year":"2022","unstructured":"Saritas T, Reinartz S, Kr\u00fcger T, et al. Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial. Clin Kidney J 2022; 15: 2300\u20132311.","journal-title":"Clin Kidney J"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab017"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114519000163"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205624"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-008-9410-3"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-014-0751-9"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019060579"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.06.011"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040404"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03460-x"},{"key":"e_1_3_3_42_2","article-title":"Effects of vitamin K supplementation on vascular calcification in chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Geng C","unstructured":"Geng C, Huang L, Pu L, et al. Effects of vitamin K supplementation on vascular calcification in chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials. Front Nutr 2023; 9: 1001826.","journal-title":"Front Nutr"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013060635"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04720416"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/cdn\/nzz077"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac171"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15163"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2019.1585372"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1177\/1179546819852941"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.5414\/CN108494"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102046"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261491505","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605261491505","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261491505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:19:10Z","timestamp":1790939950000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605261491505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/03000605261491505"],"URL":"https:\/\/doi.org\/10.1177\/03000605261491505","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"article-number":"03000605261491505"}}